BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Maryland Psychiatric Society - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mdpsych.org
X-WR-CALDESC:Events for Maryland Psychiatric Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T190000
DTEND;TZID=America/New_York:20241114T213000
DTSTAMP:20241025T145139Z
CREATED:20240909T150433Z
LAST-MODIFIED:20241025T145139Z
UID:6645-1731610800-1731619800@mdpsych.org
SUMMARY:Psychopharmacology Update: 2024
DESCRIPTION:CLICK HERE for all tickets \nFree for MPS Members\, $25 for Non-Members \nAgenda: \n7:00-7:15 Welcome and Sponsor Introductions \n7:15-7:45 David Neubauer\, M.D. \n7:45-8:15 Christopher Welsh\, M.D. \n8:15-8:45 Mary Elizabeth Yaden\, M.D. \n8:45-9:30 Question and Answer Session \nObjectives: At the conclusion of the activity participants will be able to: \n\nHighlight both current and emerging pharmacologic strategies in the treatment of all common sleep disorders\, ranging from insomnia to hypersomnia\, and even sleep-disordered breathing.\nDescribe the DSM-5 diagnosis of Gambling Disorder\, screening tools\, treatments and services available in Maryland\nUnderstand ongoing clinical research in the psychedelic medicine\, psilocybin\, and considerations for future clinical use\n\nThank you to our supporters:\n\nThe Maryland Foundation for Psychiatry\nMaryland Addiction Consultation Services\nMindWork Group\nProfessional Risk Management Services\n\nAccreditation and Designation Statement \nIn support of improving patient care\, this activity has been planned and implemented by American Psychiatric Association (APA) and the Maryland Psychiatric Society. APA is jointly accredited by the American Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC)\, to provide continuing education for the healthcare team. \nThe APA designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nFinancial Disclosures \nPlanning Committee  \nJora Hritz has no relevant financial relationships to disclose. \nJoshua Chiappelli\, M.D. has no relevant financial relationships to disclose. \nPaul Nestadt\, M.D. has no relevant financial relationships to disclose. \nFaculty Disclosures \nDavid Neubauer\, M.D. has the following financial relationships to disclose: Advisor: Idorsia Pharmaceuticals; Consultant: Eisai Inc; Advisor: Johnson & Johnson  \nMary Elizabeth Yaden\, M.D. has no relevant financial relationships to disclose. \nChirstopher Welsh\, M.D. has no relevant financial relationships to disclose. \n 
URL:https://mdpsych.org/meetings/psychopharmacology-update-2024/
LOCATION:Remote Participation Only
ORGANIZER;CN="Maryland Psychiatric Society":MAILTO:mps@mdpsych.org
END:VEVENT
END:VCALENDAR